| Cancer and fertility preservation: international recommendations from an expert meeting M Lambertini, L Del Mastro, MC Pescio, CY Andersen, HA Azim, ... BMC medicine 14, 1-16, 2016 | 499 | 2016 |
| Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis F Poggio, M Bruzzone, M Ceppi, NF Pondé, G La Valle, L Del Mastro, ... Annals of Oncology 29 (7), 1497-1508, 2018 | 431 | 2018 |
| Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic … M Lambertini, HCF Moore, RCF Leonard, S Loibl, P Munster, M Bruzzone, ... Journal of clinical oncology 36 (19), 1981-1990, 2018 | 365 | 2018 |
| Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies KS Saini, M Tagliamento, M Lambertini, R McNally, M Romano, M Leone, ... European journal of cancer 139, 43-50, 2020 | 363 | 2020 |
| ESHRE guideline: female fertility preservation ESHRE Guideline Group on Female Fertility Preservation, RA Anderson, ... Human reproduction open 2020 (4), hoaa052, 2020 | 361 | 2020 |
| Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines M Lambertini, FA Peccatori, I Demeestere, F Amant, C Wyns, ... Annals of oncology 31 (12), 1664-1678, 2020 | 340 | 2020 |
| Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies M Lambertini, L Santoro, L Del Mastro, B Nguyen, L Livraghi, D Ugolini, ... Cancer treatment reviews 49, 65-76, 2016 | 300 | 2016 |
| Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta … M Lambertini, M Ceppi, F Poggio, FA Peccatori, HA Azim Jr, D Ugolini, ... Annals of Oncology 26 (12), 2408-2419, 2015 | 256 | 2015 |
| Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting F Amant, P Berveiller, IA Boere, E Cardonick, R Fruscio, M Fumagalli, ... Annals of Oncology 30 (10), 1601-1612, 2019 | 244 | 2019 |
| Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial M Lambertini, L Boni, A Michelotti, T Gamucci, T Scotto, S Gori, ... Jama 314 (24), 2632-2640, 2015 | 237 | 2015 |
| Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized … L Del Mastro, M Ceppi, F Poggio, C Bighin, F Peccatori, I Demeestere, ... Cancer treatment reviews 40 (5), 675-683, 2014 | 230 | 2014 |
| Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective M Lambertini, A Toss, A Passaro, C Criscitiello, C Cremolini, C Cardone, ... ESMO open 5 (2), e000759, 2020 | 212 | 2020 |
| Triple-negative breast cancer: current perspective on the evolving therapeutic landscape J Mehanna, FGH Haddad, R Eid, M Lambertini, HR Kourie International journal of women's health, 431-437, 2019 | 183 | 2019 |
| Long-term safety of pregnancy following breast cancer according to estrogen receptor status M Lambertini, N Kroman, L Ameye, O Cordoba, A Pinto, G Benedetti, ... JNCI: Journal of the National Cancer Institute 110 (4), 426-429, 2018 | 182 | 2018 |
| Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis AR Ferreira, A Di Meglio, B Pistilli, AS Gbenou, M El-Mouhebb, S Dauchy, ... Annals of Oncology 30 (11), 1784-1795, 2019 | 181 | 2019 |
| Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer MA Franzoi, E Agostinetto, M Perachino, L Del Mastro, E de Azambuja, ... The Lancet Oncology 22 (7), e303-e313, 2021 | 179 | 2021 |
| Follow-up strategies for women treated for early breast cancer. M Ivan, C Michela, L Matteo, L Alessia, L Alessandro Cochrane Database Syst Rev, CD001768, 2016 | 134* | 2016 |
| Targeted agents for cancer treatment during pregnancy M Lambertini, FA Peccatori, HA Azim Jr Cancer treatment reviews 41 (4), 301-309, 2015 | 129 | 2015 |
| Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and … G Viscardi, AC Tralongo, F Massari, M Lambertini, V Mollica, A Rizzo, ... European Journal of Cancer 177, 175-185, 2022 | 128 | 2022 |
| Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective … DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ... The Lancet Oncology 22 (12), 1669-1680, 2021 | 127 | 2021 |
